Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

Recursion Pharmaceuticals is trying to prove that AI’s next big winner can also come from biotech, and not just from the tech ...

One day-long session highlighted the universality of the cyber challenges raised by more advanced AI. This includes new kinds ...

On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...

As the nation marks 250 years since the signing of the Declaration of Independence, the Smithsonian invites educators to ...

AI safety researcher resignation at OpenAI and Anthropic proved prescient: ChatGPT ads now target users based on private chat ...

Microsoft's Eric Horvitz warns of a narrowing window to understand AI systems ...

Researchers demonstrated a low cost, camera driven way to build a high resolution digital twin of every FFF print layer.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

This week’s cybersecurity recap covers Firefox and Chrome bugs, EDR-killer tools, a TV botnet, an OpenBSD flaw, Android ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.